658 related articles for article (PubMed ID: 17630119)
41. Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element.
Harke N; Leers J; Kietz S; Drenckhahn D; Förster C
Mol Cell Endocrinol; 2008 Nov; 295(1-2):39-47. PubMed ID: 18782596
[TBL] [Abstract][Full Text] [Related]
42. Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter.
Dschietzig T; Bartsch C; Wessler S; Baumann G; Stangl K
Regul Pept; 2009 Jun; 155(1-3):163-73. PubMed ID: 19289144
[TBL] [Abstract][Full Text] [Related]
43. Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids.
Dvorak Z; Pavek P
Drug Metab Rev; 2010 Nov; 42(4):621-35. PubMed ID: 20482443
[TBL] [Abstract][Full Text] [Related]
44. No association of glucocorticoid receptor polymorphisms with asthma and response to glucocorticoids.
Szczepankiewicz A; Breborowicz A; Sobkowiak P; Popiel A
Adv Med Sci; 2008; 53(2):245-50. PubMed ID: 18952539
[TBL] [Abstract][Full Text] [Related]
45. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
van Raalte DH; Ouwens DM; Diamant M
Eur J Clin Invest; 2009 Feb; 39(2):81-93. PubMed ID: 19200161
[TBL] [Abstract][Full Text] [Related]
46. It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions.
Nixon M; Andrew R; Chapman KE
Steroids; 2013 Jan; 78(1):59-68. PubMed ID: 23127816
[TBL] [Abstract][Full Text] [Related]
47. Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.
Roohk DJ; Varady KA; Turner SM; Emson CL; Gelling RW; Shankaran M; Lindwall G; Shipp LE; Scanlan TS; Wang JC; Hellerstein MK
J Pharmacol Exp Ther; 2010 Apr; 333(1):281-9. PubMed ID: 20065017
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination.
Martinez ED; Pattabiraman N; Danielsen M
Exp Cell Res; 2005 Aug; 308(2):320-33. PubMed ID: 15936754
[TBL] [Abstract][Full Text] [Related]
49. Glucocorticosteroids.
Barnes PJ
Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms and resistance in glucocorticoid control of inflammation.
Barnes PJ
J Steroid Biochem Mol Biol; 2010 May; 120(2-3):76-85. PubMed ID: 20188830
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoid receptor signaling in bone cells.
Moutsatsou P; Kassi E; Papavassiliou AG
Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718
[TBL] [Abstract][Full Text] [Related]
52. Determinants of glucocorticoid action in the bone microenvironment.
Dovio A; Micossi I; Bianco E; Angeli A
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):7-15. PubMed ID: 18791345
[TBL] [Abstract][Full Text] [Related]
53. The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation.
Hu X; Du S; Tunca C; Braden T; Long KR; Lee J; Webb EG; Dietz JD; Hummert S; Rouw S; Hegde SG; Webber RK; Obukowicz MG
Endocrinology; 2011 Aug; 152(8):3123-34. PubMed ID: 21558312
[TBL] [Abstract][Full Text] [Related]
54. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
[TBL] [Abstract][Full Text] [Related]
55. Effects of glucocorticoids on inflammation and arthritis.
Morand EF
Curr Opin Rheumatol; 2007 May; 19(3):302-7. PubMed ID: 17414960
[TBL] [Abstract][Full Text] [Related]
56. Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.
Robinson RP; Buckbinder L; Haugeto AI; McNiff PA; Millham ML; Reese MR; Schaefer JF; Abramov YA; Bordner J; Chantigny YA; Kleinman EF; Laird ER; Morgan BP; Murray JC; Salter ED; Wessel MD; Yocum SA
J Med Chem; 2009 Mar; 52(6):1731-43. PubMed ID: 19239259
[TBL] [Abstract][Full Text] [Related]
57. Discovery of quinolines as selective glucocorticoid receptor agonists.
Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
[TBL] [Abstract][Full Text] [Related]
58. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.
Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I
Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695
[TBL] [Abstract][Full Text] [Related]
59. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
[TBL] [Abstract][Full Text] [Related]
60. [Current insights into the development of new glucocorticoid receptor ligands].
Buttgereit F; Song IH; Straub RH; Burmester GR
Z Rheumatol; 2005 Apr; 64(3):170-6. PubMed ID: 15868334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
